Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,965 GBX | +0.36% | +0.82% | +9.84% |
Jun. 17 | Transcript : Hikma Pharmaceuticals PLC, Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals - M&A Call | |
Jun. 17 | Hikma adds scale to US injectables business with Xellia acquisition | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.84% | 5.51B | |
+51.82% | 791B | |
+40.45% | 630B | |
+16.95% | 328B | |
+9.49% | 298B | |
+17.25% | 246B | |
+0.41% | 225B | |
+10.22% | 218B | |
+5.30% | 160B | |
-6.29% | 156B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC, H1 2022 Pre Recorded Earnings Call, Aug 04, 2022